Literature DB >> 32082855

Can functional inoperability in lung cancer patients be changed by pulmonary rehabilitation?

Esra Pehlivan1, Arif Balcı1, Lütfiye Kılıç1.   

Abstract

BACKGROUND: This study aims to investigate the effects of shortterm intense pulmonary rehabilitation on respiratory function in patients with lung cancer who were defined as inoperable due to insufficient pulmonary reserve.
METHODS: A total of 25 patients (24 males, 1 female; mean age 62 years; range, 50 to 72 years) who were histologically diagnosed as non-small cell lung carcinoma, considered functionally inoperable due to high risk of an estimated postoperative complication, and suitable for surgical resection according to tumor stage were included in the study. Patients received chest physiotherapy, self-walking and inspiratory muscle training for two weeks. The forced expiratory volume in one second, forced vital capacity, modified Medical Research Council dyspnea scale, six-minute walking distance, maximal inspiratory and expiratory pressures for respiratory muscle strength measurements, and predicted peak maximal oxygen consumption were examined.
RESULTS: After pulmonary rehabilitation, there was statistically significant improvement in the six-minute walking distance (53 m, p<0.001), dyspnea perception (p<0.001), maximal inspiratory pressure (12 cm H2O, p<0.001), forced vital capacity (p<0.001), predicted forced expiratory volume in one second (%) (p=0.001), forced expiratory volume in one second (Δ forced expiratory volume in one second= 150 mL, p=0.001; Δ maximum value of forced expiratory volume in one second: 650 mL), and predicted maximal oxygen consumption (p<0.001). At the end of the rehabilitation, 60% of the patients (n=15) reevaluated by the surgeons could be operated.
CONCLUSION: Short-term intensive pulmonary rehabilitation improves lung functions and exercise capacity while decreasing dyspnea perception. In our study, thanks to the gains derived from the exercise, approximately more than half of the patients could be operated. Therefore, it may be useful to refer patients to rehabilitation before establishing a decision of inoperability.
Copyright © 2019, Turkish League Against Rheumatism.

Entities:  

Keywords:  Exercise; inoperable; lung cancer; lung function; pulmonary rehabilitation; walk test

Year:  2019        PMID: 32082855      PMCID: PMC7021394          DOI: 10.5606/tgkdc.dergisi.2019.16474

Source DB:  PubMed          Journal:  Turk Gogus Kalp Damar Cerrahisi Derg        ISSN: 1301-5680            Impact factor:   0.332


  28 in total

1.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

2.  American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation.

Authors:  Linda Nici; Claudio Donner; Emiel Wouters; Richard Zuwallack; Nicolino Ambrosino; Jean Bourbeau; Mauro Carone; Bartolome Celli; Marielle Engelen; Bonnie Fahy; Chris Garvey; Roger Goldstein; Rik Gosselink; Suzanne Lareau; Neil MacIntyre; Francois Maltais; Mike Morgan; Denis O'Donnell; Christian Prefault; Jane Reardon; Carolyn Rochester; Annemie Schols; Sally Singh; Thierry Troosters
Journal:  Am J Respir Crit Care Med       Date:  2006-06-15       Impact factor: 21.405

Review 3.  Preoperative evaluation for lung cancer resection.

Authors:  Dionysios Spyratos; Paul Zarogoulidis; Konstantinos Porpodis; Nikolaos Angelis; Antonios Papaiwannou; Ioannis Kioumis; Georgia Pitsiou; Athanasia Pataka; Kosmas Tsakiridis; Andreas Mpakas; Stamatis Arikas; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Theodora Tsiouda; Nikolaos Machairiotis; Stavros Siminelakis; Michael Argyriou; Maria Kotsakou; George Kessis; Alexander Kolettas; Thomas Beleveslis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

4.  Preoperative pulmonary rehabilitation before lung cancer resection: results from two randomized studies.

Authors:  Roberto Benzo; Dennis Wigle; Paul Novotny; Marnie Wetzstein; Francis Nichols; Robert K Shen; Steve Cassivi; Claude Deschamps
Journal:  Lung Cancer       Date:  2011-06-12       Impact factor: 5.705

5.  Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease.

Authors:  R Casaburi; J Porszasz; M R Burns; E R Carithers; R S Chang; C B Cooper
Journal:  Am J Respir Crit Care Med       Date:  1997-05       Impact factor: 21.405

6.  [Mechanism of lung cancer and chronic obstructive pulmonary disease].

Authors:  Tiao Li; Xue He; Yan Chen
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2017-10-28

7.  Cardiopulmonary exercise tests and lung cancer surgical outcome.

Authors:  Thida Win; Arlene Jackson; Linda Sharples; Ashley M Groves; Francis C Wells; Andrew J Ritchie; Clare M Laroche
Journal:  Chest       Date:  2005-04       Impact factor: 9.410

8.  The impact of decreasing cutoff values for maximal oxygen consumption (VO(2)max) in the decision-making process for candidates to lung cancer surgery.

Authors:  Gaetano Rocco; Tindaro Gatani; Massimo Di Maio; Ilernando Meoli; Antonello La Rocca; Nicola Martucci; Carmine La Manna; Francesco Stefanelli
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

9.  Preoperative therapy restores ventilatory parameters and reduces length of stay in patients undergoing myocardial revascularization.

Authors:  Moises Teixeira Sobrinho; Gabriel Negretti Guirado; Marcos Augusto de Moraes Silva
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Apr-Jun

10.  Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.

Authors:  Alison Pearce; Marion Haas; Rosalie Viney; Sallie-Anne Pearson; Philip Haywood; Chris Brown; Robyn Ward
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

View more
  1 in total

1.  Usefulness of Pulmonary Rehabilitation in Non-Small Cell Lung Cancer Patients Based on Pulmonary Function Tests and Muscle Analysis Using Computed Tomography Images.

Authors:  Juwhan Choi; Zepa Yang; Jinhwan Lee; Jun Hee Lee; Hyun Koo Kim; Hwan Seok Yong; Sung Yong Lee
Journal:  Cancer Res Treat       Date:  2021-10-20       Impact factor: 5.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.